Translational control of eIF5A in various diseases

Amino Acids

Volumn 42, Issue 2-3, 2012, Pages 679-684

  Kaiser, Annette ^a  

^a TH Köln University of Applied Sciences   (Germany)

Author keywords

Cancer; Diabetes; EIF5A; HIV; Hypusine; Malaria; Translation

Indexed keywords

1,7 DIAMINOHEPTANE; ANTIDIABETIC AGENT; ANTIRETROVIRUS AGENT; CICLOPIROX; GC 7; HYPUSINE; IMATINIB; INITIATION FACTOR 5A; INSULIN; MESSENGER RNA; N 1 GUANYL 1,7 DIAMINOHEPTANE; UNCLASSIFIED DRUG; INITIATION FACTOR; RNA BINDING PROTEIN;

CANCER CELL; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; GENETIC ASSOCIATION; HALF LIFE TIME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPUSINATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; LIPODYSTROPHY; MALARIA; MITOCHONDRIAL TOXICITY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOPOROSIS; PATHOGENICITY; PLASMODIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN RNA BINDING; PROTEIN TARGETING; REVIEW; RNA SEQUENCE; TRANSLATION INITIATION; TRANSLATION REGULATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PHYSIOLOGY; PROTEIN SYNTHESIS;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1;

DIABETES MELLITUS; HIV INFECTIONS; HUMANS; PEPTIDE INITIATION FACTORS; PLASMODIUM; PROTEIN BIOSYNTHESIS; RNA-BINDING PROTEINS;

EID: 84861687759     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-1042-8     Document Type: Review

References (38)

1. Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, Doumbo OK, Greenwood B, Hall BF, Levine MM, Mendis K, Newman RD, Plowe CV, Rodríguez MH, Sinden R, Slutsker L, Tanner M (2011) A research agenda to underpin malaria eradication. PLoS Med 25:e1000406
2. Balabanov S, Gontarewicz A, Ziegler P, Hartmann U, Kammer W, Copland M, Brassat U, Priemer M, Hauber I, Wilhelm T, Schwarz G, Kanz L, Bokemeyer C, Hauber J, Holyoake TL, Nordheim A, Brümmendorf TH (2007) Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach. Blood 109(4):1701-1711 (Pubitemid 46239605)
3. Baum J, Papenfuss AT, Mair GR, Janse CJ, Vlachou D, Waters AP, Cowman AF, Crabb CJ, Koning-Ward TF (2010) Molecular genetics and comparative genomics reveal RNAi is not functional in malaria parasites. Nucleic Acids Res 37:3788-3798
4. Bevec D, Jaksche H, Oft M, Wöhl T, Himmelspach M, Pacher A, Schebesta M, Koettnitz K, Dobrovnik M, Csonga R, Lottspeich F, Hauber J (1996) Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science 271: 1858-1860
5. Blavid R, Kusch P, Hauber J, Eschweiler U, Sarite SR, Specht S, Deininger S, Hoerauf A, Kaiser A (2010) Down-regulation of hypusine biosynthesis in Plasmodium by inhibition of S-adenosyl- methionine-decarboxylase. Amino Acids 38:461-469
6. Cracchiolo BM, Heller DS, Clement PM, Wolff EC, Park MH, Hanauske-Abel HM (2004) Eukaryotic initiation factor 5A-1 (eIF5A-1) as a diagnostic marker for aberrant proliferation in intraepithelial neoplasia of the vulva. Gynecol Oncol 94:217-222 (Pubitemid 38950524)
7. Dasaradhi PV, Mohammed A, Kumar A, Hossain MJ, Bhatnagar RK, Chauhan VS, Malhotra P (2005) A role of falcipain-2, principle cysteine proteases of Plasmodium falciparum in merozoite egression. Biochem Biophys Res Commun 336:1062-1068 (Pubitemid 41383430)
8. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK (2002) Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med 137:381-433
9. Evans-Molina C, Robbins RD, Kono T, Tersey SA, Vestermark GL, Nunemaker CS, Garmey JC, Deering TG, Keller SR, Maier B, Mirmira RG (2009) Peroxisome proliferator-activated receptor gamma activation restores islet function in diabetic mice through reduction of endoplasmic reticulum stress and maintenance of euchromatin structure. Mol Cell Biol 29:2053-2067
10. Gissot M, Brique S, Refour P, Boschet C, Vaquero C (2005) PfMyb1, a Plasmodium falciparum transcription factor, is required for intra-erythrocytic growth and controls key genes for cell cycle regulation. J Mol Biol 34:29-42 (Pubitemid 40128304)
11. Gregio AP, Cano VP, Avaca JS, Valentini SR, Zanelli CF (2009) EIF- 5A has a function in the elongation step of translation in yeast. Biochem Biophys Res Commun 380:785-790
12. Hanauske-Abel HM, Slowinska B, Zagulska S, Wilson RC, Staiano- Coico L, Hanauske AR, McCaffrey T, Szabo P (1995) Detection of a sub-set of polysomal mRNAs associated with modulation of hypusine formation at the G1-S boundary. Proposal of a role for eIF-5A in onset of DNA replication. FEBS Lett 366:92-98
13. Hauber J (2010) Revisiting an old acquaintance: role for eIF5A in diabetes. J Clin Invest 120:1806-1868
14. Hauber I, Bevec D, Heukeshoven J, Krätzer F, Horn F, Choidas A, Harrer T, Hauber J (2005) Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J Clin Invest 115:76-85 (Pubitemid 40385507)
15. Hofmann W, Reichart B, Ewald A, Mü ller E, Schmitt I, Stauber RH, Lottspeich F, Jockusch BM, Scheer U, Hauber J, Dabauvalle MC (2001) Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)- containing retroviral RNAs. An unexpected role for actin. J Cell Biol 152:895-910 (Pubitemid 34286067)
16. Igarashi K, Kashiwagi K (2010) Modulation of cellular function by polyamines. Int J Biochem Cell Biol 42:39-51
17. Kaiser A (2009) Targeting malaria polyamines: enzymes of the hypusine pathway are novel drug targets in the prevention and therapy of malaria. In: Dendrifosse G (ed) Biological aspects of biogenic amines, polyamines and conjugates. Research Signpost, pp 421-439
18. Kaiser A, Hammels I, Gottwald A, Nassar M, Zaghloul MS, Motaal BA, Hauber J, Hoerauf A (2007) Modification of eukaryotic initiation factor 5A from Plasmodium vivax by a truncated deoxyhypusine synthase from Plasmodium falciparum: An enzyme with dual enzymatic properties. Bioorg Med Chem 15:6200-6207 (Pubitemid 47096794)
19. Kemper WM, Berry KW, Merrick WC (1976) Purification and properties of rabbit reticulocyte protein synthesis initiation factors M2Balpha and M2Bbeta. J Biol Chem 251:5551-5557
20. Kumar R, Adams B, Oldenburg A, Musiyenko A, Barik S (2002) Characterisation and expression of a PP1 serine/threonine protein phosphatase (PfPP1) from the malaria parasite, Plasmodium falciparum: demonstration of its essential role using RNA interference. Malar J 145:1245-1254
21. Lam F, Jankova L, Dent OF, Molloy MP, Kwun SY, Clarke C, Chapuis P, Robertson G, Beale P, Clarke S, Bokey EL, Chan C (2010) Identification of distinctive protein expression patterns in colorectal adenoma. Proteomics Clin Appl 4:60-70
22. Lee NP, Tsang FH, Shek FH, Mao M, Dai H, Zhang C, Dong S, Guan XY, Poon RT, Luk JM (2010) Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma. Int J Cancer 15: 968-976
23. Maier B, Ogihara T, Trace AP, Tersey SA, Robbins RD, Chakrabarti SK, Nunemaker CS, Stull ND, Taylor CA, Thompson JE, Dondero RS, Lewis EC, Dinarello CA, Nadler JL, Mirmira RG (2010a) The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest 120:2156-2170
24. Maier B, Tersey SA, Mirmira RG (2010b) Hypusine: a new target for therapeutic intervention in diabetic inflammation. Discov Med. 10(50):18-23
25. Mathis D, Vence L, Benoist C (2001) Beta-Cell death during progression to diabetes. Nature 13:792-798
26. McRobert L, McConkey (2002) RNA interference (RNAi) inhibits growth of P. falciparum. Mol Chem Parasitol 119:273-278 (Pubitemid 34114066)
27. Molitor IM, Knöbel S, Dang C, Spielmann T, Alléra A, König GM (2004) Translation initiation factor eIF-5A from Plasmodium falciparum. Mol Biochem Parasitol 137:65-74 (Pubitemid 38987943)
28. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338:853-860 (Pubitemid 28135961)
29. Park MH, Nishimura K, Zanelli CF, Valentini SR (2010) Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids 238:491-500
30. Pollard VW, Malim MH (1998) The HIV-1 Rev protein. Annu Rev Microbiol 52:491-532 (Pubitemid 28481200)
31. Saini P, Eyler DE, Green R, Dever TE (2009) Hypusine-containing protein eIF-5A promotes translation elongation. Nature 459:118-121
32. Silvera D, Formenti SC, Schneider RJ (2010) Translational control in cancer. Nat Rev Cancer 10:254-266
33. Tuteja R, Pradhan A, Sharma S (2008) Plasmodium falciparum signal peptidase is regulated by phosphorylation and required for intraerythrocytic growth. Mol Biochem Parasitol 157:137-147
34. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes:estimates for the year 2010 and projections for 2030. Diabetes Care 27:1047-1053 (Pubitemid 38579764)
35. Wolff EC, Kang KR, Kim YS, Park MH (2007) Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification. Amino Acids 33:341-350 (Pubitemid 47222971)
36. Zanelli CF, Valentini SR (2007) Is there a role for eIF5A in translation? Amino Acids 33:351-358 (Pubitemid 47222979)
37. Zanelli CF, Maragno AL, Gregio AP, Komili S, Pandolfi JR, Mestriner CA, Lustri WR, Valentini SR (2006) eIF5A binds to translational machinery components and affects translation in yeast. Biochem Biophys Res Commun 348:1358-1366 (Pubitemid 44291350)
38. Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, Ma B, Zender P, Kubicka S, Luk JM, Schirmacher P, McCombie WR, Wigler M, Hicks J, Hannon GJ, Powers S, Lowe SW (2008) An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 135:852-864